Literature DB >> 32913067

Asymptomatic man with an incidental finding of a massive empyema.

Kashvi Gupta1, Elena Stuewe2, Marianne Barry2.   

Abstract

We describe the case of a 67-year-old asymptomatic man who was referred to our hospital for abnormal laboratory results. He was incidentally found to have a massive empyema without underlying bronchopulmonary pneumonia. Following thoracentesis, he was diagnosed with chronic Streptococcus anginosus empyema. Therapeutic thoracentesis and treatment with tissue plasminogen activator and deoxyribonuclease failed to resolve the empyema, and there was residual loculated pleural fluid that was surrounded by a thick rind. The patient was referred to thoracic surgery for decortication of the pleural space via video-assisted thoracoscopic surgery. At 2-month follow-up, the patient had complete re-expansion of the lung tissue. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cardiothoracic surgery; empyema; medical management

Mesh:

Substances:

Year:  2020        PMID: 32913067      PMCID: PMC7484871          DOI: 10.1136/bcr-2020-237178

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

Review 1.  Molecular pathogenicity of Streptococcus anginosus.

Authors:  D Asam; B Spellerberg
Journal:  Mol Oral Microbiol       Date:  2014-06-26       Impact factor: 3.563

2.  Emergence of parapneumonic empyema in the USA.

Authors:  Carlos G Grijalva; Yuwei Zhu; J Pekka Nuorti; Marie R Griffin
Journal:  Thorax       Date:  2011-05-26       Impact factor: 9.139

3.  Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial.

Authors:  Ramon Luengo-Fernandez; Erika Penz; Melissa Dobson; Ioannis Psallidas; Andrew J Nunn; Nick A Maskell; Najib M Rahman
Journal:  Eur Respir J       Date:  2019-08-01       Impact factor: 16.671

4.  Streptococcus anginosus infections: crossing tissue planes.

Authors:  Bernie Y Sunwoo; Wallace T Miller
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

5.  Bacteriology and clinical outcomes of patients with culture-positive pleural infection in Western Australia: A 6-year analysis.

Authors:  Fraser Brims; Natalia Popowicz; Andrew Rosenstengel; Julie Hart; Arthee Yogendran; Catherine A Read; Felicity Lee; Ranjan Shrestha; Alexander Franke; Joshua R Lewis; Ian Kay; Grant Waterer; Y C Gary Lee
Journal:  Respirology       Date:  2018-09-06       Impact factor: 6.424

6.  (F)utility of computed tomography of the chest in the presence of pleural effusion.

Authors:  Tilak Pathak; Malvinder S Parmar
Journal:  Pleura Peritoneum       Date:  2017-11-08

7.  Intrapleural use of tissue plasminogen activator and DNase in pleural infection.

Authors:  Najib M Rahman; Nicholas A Maskell; Alex West; Richard Teoh; Anthony Arnold; Carolyn Mackinlay; Daniel Peckham; Chris W H Davies; Nabeel Ali; William Kinnear; Andrew Bentley; Brennan C Kahan; John M Wrightson; Helen E Davies; Clare E Hooper; Y C Gary Lee; Emma L Hedley; Nicky Crosthwaite; Louise Choo; Emma J Helm; Fergus V Gleeson; Andrew J Nunn; Robert J O Davies
Journal:  N Engl J Med       Date:  2011-08-11       Impact factor: 91.245

  7 in total
  1 in total

1.  Post COVID-19 pulmonary complications; a single center experience.

Authors:  Okba F Ahmed; Fahmi H Kakamad; Bnar J Hama Amin; Berwn A Abdullah; Marwan N Hassan; Rawezh Q Salih; Shvan H Mohammed; Snur Othman; Gasha S Ahmed; Abdulwahid M Salih
Journal:  Ann Med Surg (Lond)       Date:  2021-11-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.